Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults

Clinical trial NCT02399345 · COMPLETED

Trial details

NCT number

NCT02399345

Sponsor

AbbVie

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2015-03-01

Primary completion

2015-11-01

Enrollment

10

View on ClinicalTrials.gov